Rofecoxib /ˌrɒfᵻˈkɒksɪb/ is a nonsteroidal anti-inflammatory drug (NSAID) that
has now .... The VIGOR (Vioxx GI Outcomes Research) study, conducted by
Bombardier, et a...
Oct 16, 2015 ... Merck's Vioxx was a popular NSAID pain reliever before studies revealed it
causes heart attacks, strokes and death. Lawsuits surpass 60000.
What action did Merck take today? Merck announced a voluntary worldwide
withdrawal of Vioxx (rofecoxib). 2. What is Vioxx? Vioxx is a COX-2 selective ...
Learn about Vioxx (Rofecoxib) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related medications.
Merck removed one of the world's best-selling painkillers from the market in 2004
after a study showed Vioxx caused an increased risk of serious cardiovascular ...
Vioxx is a COX-2 inhibitor that was originally approved by the FDA in 1999 to be
used for pain relief and reducing inflammation for patients with osteoarthritis, ...
Nov 10, 2007 ... Shortly before the FDA approved Vioxx in 1999, drug maker Merck launched a
study it hoped would prove that Vioxx was superior to older ...
Oct 6, 2004 ... Merck & Co.'s arthritis drug Vioxx may have led to more than 27000 heart attacks
and sudden cardiac deaths before it was pulled from the ...
Vioxx is a type of non-steroidal anti-inflammatory drug (NSAID). It goes by the
generic name rofecoxib and is a relative of more familiar NSAIDs such as ...
Oct 7, 2004 ... Now that we know Vioxx wasn't safe, can we trust its sister drugs, Bextra and